1. Home
  2. SKYT vs AMPH Comparison

SKYT vs AMPH Comparison

Compare SKYT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWater Technology Inc.

SKYT

SkyWater Technology Inc.

HOLD

Current Price

$30.28

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$21.57

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYT
AMPH
Founded
1991
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
SKYT
AMPH
Price
$30.28
$21.57
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
$26.50
$28.38
AVG Volume (30 Days)
1.1M
408.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
1842.86
N/A
EPS
2.44
2.03
Revenue
$442,139,000.00
$719,887,000.00
Revenue This Year
$40.16
$6.90
Revenue Next Year
$4.52
$4.64
P/E Ratio
$12.74
$10.76
Revenue Growth
29.18
N/A
52 Week Low
$6.99
$17.03
52 Week High
$36.07
$31.26

Technical Indicators

Market Signals
Indicator
SKYT
AMPH
Relative Strength Index (RSI) 47.37 52.62
Support Level $29.80 $20.39
Resistance Level $31.19 $23.08
Average True Range (ATR) 1.18 0.78
MACD -0.14 0.09
Stochastic Oscillator 34.42 45.83

Price Performance

Historical Comparison
SKYT
AMPH

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: